Serum <scp>B</scp>‐cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survivalEric Sanchez, James R. Berenson, Ralph V. Boccia et al.|British Journal of Haematology|2012Cited by 277
Monoclonal gammopathy of undetermined significance: a consensus statementJames R. Berenson, Robert A. Kyle, Kenneth C. Anderson et al.|British Journal of Haematology|2010Cited by 119
Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapyJames R. Berenson, Robert Vescio, James Hilger et al.|Leukemia|2014Cited by 76
Zoledronic Acid Markedly Improves Bone Mineral Density for Patients with Monoclonal Gammopathy of Undetermined Significance and Bone LossJames R. Berenson, Regina A. Swift, Ori Yellin et al.|Clinical Cancer Research|2008Cited by 70
Phase <scp>I</scp>/<scp>II</scp> trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myelomaJames R. Berenson, Debra Mayo, Ori Yellin et al.|British Journal of Haematology|2012Cited by 53